Published in Am J Public Health on November 01, 1990
Caffeine use in children: what we know, what we have left to learn, and why we should worry. Neurosci Biobehav Rev (2009) 1.87
Does coffee drinking increase the risk of coronary heart disease? Results from a meta-analysis. Br Heart J (1994) 1.60
Wake up and smell the coffee. Caffeine, coffee, and the medical consequences. West J Med (1992) 0.91
Relationship between long-term coffee consumption and components of the metabolic syndrome: the Amsterdam Growth and Health Longitudinal Study. Eur J Epidemiol (2009) 0.90
Greater coffee intake in men is associated with steeper age-related increases in blood pressure. Am J Hypertens (2010) 0.76
Caffeine under examination--a passing grade. West J Med (1992) 0.75
Cardiovascular Effects of Caffeine: Misconceptions about caffeine use and caronary heart disease. Can Fam Physician (1992) 0.75
Relationship of physical health status and health practices. Prev Med (1972) 6.29
Relationship of health practices and mortality. Prev Med (1973) 4.42
A longitudinal study of coronary heart disease. Circulation (1963) 4.30
A multivariate analysis of health-related practices: a nine-year mortality follow-up of the Alameda County Study. Am J Epidemiol (1982) 3.32
Dietary calcium and risk of hip fracture: 14-year prospective population study. Lancet (1988) 2.05
Dose-related sleep disturbances induced by coffee and caffeine. Clin Pharmacol Ther (1976) 2.04
Dietary potassium and stroke-associated mortality. A 12-year prospective population study. N Engl J Med (1987) 1.95
Coffee and myocardial infarction. N Engl J Med (1973) 1.66
Cigarette smoking and increased central adiposity. Ann Intern Med (1989) 1.59
Personal health practices and mortality among the elderly. Am J Public Health (1984) 1.58
Coffee consumption and mortality in the Chicago Western Electric Company Study. Am J Epidemiol (1987) 1.51
Coffee consumption and the incidence of coronary heart disease. N Engl J Med (1986) 1.36
Caffeine and coffee: their influence on metabolic rate and substrate utilization in normal weight and obese individuals. Am J Clin Nutr (1980) 1.34
Dietary fiber and reduced ischemic heart disease mortality rates in men and women: a 12-year prospective study. Am J Epidemiol (1987) 1.21
Coffee drinking and death due to coronary heart disease. N Engl J Med (1976) 1.19
Errors in reported dietary intakes. II. Long-term recall. Am J Epidemiol (1988) 1.13
Relationship of physical characteristics and life habits to treadmill exercise capacity. Am J Epidemiol (1981) 1.11
A community study of alcohol and other factors associated with the distribution of high density lipoprotein cholesterol in older vs. younger men. Am J Epidemiol (1982) 1.07
Co-occurrent use of cigarettes, alcohol, and coffee in healthy, community-living men and women. Health Psychol (1985) 1.06
Coffee, dietary habits, and serum cholesterol among men and women 35-49 years of age. Am J Epidemiol (1989) 1.02
Levels and interrelationships of serum and lipoprotein cholesterol and triglycerides. Association with adiposity and the consumption of ethanol, tobacco, and beverages containing caffeine. Arteriosclerosis (1981) 0.97
Coffee consumption, diet, and lipids. Am J Epidemiol (1985) 0.96
Stimulants and coronaries. Postgrad Med (1968) 0.95
Dairy products, calcium, and blood pressure. Am J Clin Nutr (1983) 0.94
Coffee, plasma cholesterol, and lipoproteins. A population study in an adult community. Am J Epidemiol (1985) 0.91
The Tromsø Heart Study: food habits, serum total cholesterol, HDL cholesterol, and triglycerides. Am J Epidemiol (1987) 0.90
Coffee, caffeine, and serum cholesterol in Japanese men in Hawaii. Am J Epidemiol (1986) 0.89
Dietary potassium and blood pressure in a population. Am J Clin Nutr (1984) 0.89
The Tromsø Heart Study: is coffee drinking an indicator of a life style with high risk for ischemic heart disease? Acta Med Scand (1987) 0.87
Weak associations in nutritional epidemiology: the importance of replication of observations on individuals. Int J Epidemiol (1988) 0.80
Coffee, cocktails and coronary candidates. N Engl J Med (1977) 0.80
Evaluating coronary risk factors. N Engl J Med (1979) 0.77
Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA (1999) 11.23
Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology (1997) 9.70
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20
Central obesity and increased risk of dementia more than three decades later. Neurology (2008) 6.03
The nonvalue of sputum culture in the diagnosis of pneumococcal pneumonia. Am Rev Respir Dis (1971) 4.88
Patient preferences for colorectal cancer screening. J Fam Pract (1997) 4.55
Differences between respondents and non-respondents in a population-based cardiovascular disease study. Am J Epidemiol (1978) 3.90
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation (1987) 3.49
Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology (2004) 3.47
Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature. Medicine (Baltimore) (1971) 3.40
The prevalence of peripheral arterial disease in a defined population. Circulation (1985) 2.88
Latent and chronic infections imported from Southeast Asia. JAMA (1978) 2.78
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet (1985) 2.62
The epidemiology of head injury: a prospective study of an entire community-San Diego County, California, 1978. Am J Epidemiol (1981) 2.58
Estrogen use and all-cause mortality. Preliminary results from the Lipid Research Clinics Program Follow-Up Study. JAMA (1983) 2.57
Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop. Ann Epidemiol (1994) 2.50
Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation (1999) 2.31
Exercise patterns in a population of older adults. Am J Prev Med (1989) 2.28
The Medicaid Rx model: pharmacy-based risk adjustment for public programs. Med Care (2001) 2.26
The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int (2006) 2.24
Prevalence of hypertension, dyslipidemia, and dyslipidemic hypertension. J Fam Pract (1994) 2.21
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer (2011) 2.20
A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med (1986) 2.18
Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group. Circulation (1997) 2.17
Retest reliability of plasma cholesterol and triglyceride. The Lipid Research Clinics Prevalence Study. Am J Epidemiol (1982) 2.15
Cognitive and functional status of the oldest old. J Am Geriatr Soc (1996) 2.14
Effects of passive smoking on ischemic heart disease mortality of nonsmokers. A prospective study. Am J Epidemiol (1985) 2.12
Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS). Circulation (2001) 2.12
Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. Am J Epidemiol (1997) 2.06
A prospective population-based study of alcohol use and non-insulin-dependent diabetes mellitus. Am J Epidemiol (1990) 2.05
Dietary calcium and risk of hip fracture: 14-year prospective population study. Lancet (1988) 2.05
The effect of parity on the later development of non-insulin-dependent diabetes mellitus or impaired glucose tolerance. N Engl J Med (1989) 2.03
Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study. J Bone Miner Res (1997) 2.03
Circumcision reevaluated. West J Med (1989) 2.00
A prospective study of alcohol consumption and bone mineral density. BMJ (1993) 1.99
Depressive symptoms in overweight and obese older adults: a test of the "jolly fat" hypothesis. J Psychosom Res (1996) 1.97
Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial. Arch Intern Med (1998) 1.96
Noncontraceptive estrogen use and cardiovascular disease. Epidemiol Rev (1985) 1.95
Dietary potassium and stroke-associated mortality. A 12-year prospective population study. N Engl J Med (1987) 1.95
GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study. Diabetes Care (1996) 1.90
Physical exercise, sports, and lung function in smoking versus nonsmoking adolescents. Eur Respir J (2002) 1.89
Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Endocrinol Metab (2000) 1.88
Cigarette smoking and levels of adrenal androgens in postmenopausal women. N Engl J Med (1988) 1.88
Cognitive function in postmenopausal women treated with raloxifene. N Engl J Med (2001) 1.87
Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Am J Epidemiol (1998) 1.86
Health problems in teenage daily smokers versus nonsmokers, Norway, 1995-1997: the Nord-Trøndelag Health Study. Am J Epidemiol (2000) 1.85
Relation between body size and bone mineral density in elderly men and women. Am J Epidemiol (1993) 1.81
Effects of estrogen and estrogen-progestin on mammographic parenchymal density. Postmenopausal Estrogen/Progestin Interventions (PEPI) Investigators. Ann Intern Med (1999) 1.81
Universal neonatal hepatitis B immunization--are we jumping on the bandwagon too early? J Fam Pract (1993) 1.80
The postwar hospitalization experience of U.S. veterans of the Persian Gulf War. N Engl J Med (1996) 1.77
The effect of response bias on the odds ratio. Am J Epidemiol (1981) 1.73
Family history of heart attack as an independent predictor of death due to cardiovascular disease. Circulation (1984) 1.73
Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstet Gynecol (1998) 1.70
Ischemic heart disease risk factors after age 50. J Chronic Dis (1984) 1.69
Sex differential in ischemic heart disease mortality in diabetics: a prospective population-based study. Am J Epidemiol (1983) 1.66
Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study. Osteoporos Int (2007) 1.61
The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. J Clin Endocrinol Metab (2015) 1.61
Diabetes and pancreatic carcinoma. Diabete Metab (1994) 1.59
A prospective study of Type 2 diabetes and depressive symptoms in the elderly: the Rancho Bernardo Study. Diabet Med (2004) 1.58
Estrogen replacement therapy and the risk of venous thrombosis. Am J Med (1992) 1.58
Chemoprophylaxis of malaria for travelers. Ann Intern Med (1974) 1.55
The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population. Circulation (1985) 1.52
Pregnancy and lactation as determinants of bone mineral density in postmenopausal women. Am J Epidemiol (1992) 1.52
Effects of hormone replacement therapy on clinical fractures and height loss: The Heart and Estrogen/Progestin Replacement Study (HERS). Am J Med (2001) 1.51
Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study. Diabet Med (2013) 1.51
A prospective study of bone loss in menopausal Australian-born women. Osteoporos Int (1998) 1.50
Long-term postmenopausal hormone use, obesity, and fat distribution in older women. JAMA (1996) 1.48
The Quality of Well-Being Scale: critical similarities and differences with SF-36. Int J Qual Health Care (1998) 1.46
The sex differential in mortality from all causes and ischemic heart disease. Am J Epidemiol (1983) 1.46
Alcohol consumption and blood pressure. The lipid research clinics prevalence study. Hypertension (1982) 1.44
The association between blood pressure, age, and dietary sodium and potassium: a population study. Circulation (1988) 1.43
Ultrasound-guided liver biopsy for parenchymal liver disease: an economic analysis. Dig Dis Sci (1998) 1.41
25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology (2009) 1.40
Preventive medicine and public health: advances in prenatal screening. West J Med (1990) 1.40
Current indications for hormone replacement therapy. Natl Med J India (1999) 1.39
Fasting plasma glucose, uric acid, and triglycerides as predictors of the ratio of total cholesterol to HDL-C. Am J Clin Pathol (1984) 1.37
Judging the guidelines for colorectal cancer screening. Am Fam Physician (1997) 1.37
Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care (2000) 1.34
Lower endogenous androgens predict central adiposity in men. Ann Epidemiol (1992) 1.32
Total, LDL, and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984-1994. Circulation (1997) 1.31
Cholesterol, lipoproteins, and coronary heart disease in women. Clin Chem (1988) 1.31
Early menopause, number of reproductive years, and bone mineral density in postmenopausal women. Am J Public Health (1993) 1.30
Cholelithiasis in sickle cell anemia. Am J Med (1968) 1.30
Clustering of cardiovascular disease risk factors. Prev Med (1980) 1.29
Is insulin-dependent diabetes mellitus caused by coxsackievirus B infection? A review of the epidemiologic evidence. Rev Infect Dis (1985) 1.29
Type 2 diabetes and depressive symptoms in older adults: a population-based study. Diabet Med (1991) 1.28
Driving cessation: what older former drivers tell us. J Am Geriatr Soc (2001) 1.28
Caffeine intake and endogenous sex steroid levels in postmenopausal women. The Rancho Bernardo Study. Am J Epidemiol (1996) 1.27
Sex hormones and postmenopausal breast cancer: a prospective study in an adult community. Am J Epidemiol (1992) 1.27
Interrelation between plasma sex hormone-binding globulin and plasma insulin in healthy adult women: the telecom study. J Clin Endocrinol Metab (1993) 1.27
Blood pressure change and survival after age 75. Hypertension (1993) 1.27
Cross-sectional and prospective study of exercise and depressed mood in the elderly : the Rancho Bernardo study. Am J Epidemiol (2001) 1.26
Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group. Arthritis Rheum (1999) 1.26
Extraintestinal manifestations of shigellosis. Am J Gastroenterol (1970) 1.25
Increased postwar symptoms and psychological morbidity among U.S. Navy Gulf War veterans. Am J Trop Med Hyg (1999) 1.25